Home > > > > Report Detail

Global Genomics In Cancer Care Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 09-Nov-2022
No. of pages: 160
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Genomics In Cancer Care companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Genomics In Cancer Care market. Further, it explains the major drivers and regional dynamics of the global Genomics In Cancer Care market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Illumina

- Thermo Fisher scientific

- Agilent

- Roche

- Cancer Genetics

- Beckman Coulter

- Bio-Rad

- Danaher

- Sigma Aldrich

- Pacific Biosciences

- Quest Diagnostics

- Luminex

- Oxford Gene Technology

- PerkinElmer

- Qiagen

- GE Healthcare

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Genomics In Cancer Care Segment by Type

- Instruments

- Consumables

- Services

Genomics In Cancer Care Segment by Application

- Diagnostics

- Personalized Medicine

- Drug Discovery

- Development

- Research

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Genomics In Cancer Care market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Genomics In Cancer Care market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Genomics In Cancer Care, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Genomics In Cancer Care, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Genomics In Cancer Care revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Genomics In Cancer Care market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Genomics In Cancer Care revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Illumina, Thermo Fisher scientific, Agilent, Roche, Cancer Genetics, Beckman Coulter, Bio-Rad, Danaher and Sigma Aldrich, etc.

Global Genomics In Cancer Care Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomics In Cancer Care Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Instruments
1.2.3 Consumables
1.2.4 Services
1.3 Market by Application
1.3.1 Global Genomics In Cancer Care Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Diagnostics
1.3.3 Personalized Medicine
1.3.4 Drug Discovery
1.3.5 Development
1.3.6 Research
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Genomics In Cancer Care Market Size (2017-2028)
2.2 Genomics In Cancer Care Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Genomics In Cancer Care Market Size by Region (2017-2022)
2.4 Global Genomics In Cancer Care Market Size Forecast by Region (2023-2028)
2.5 Global Top Genomics In Cancer Care Countries Ranking by Market Size
3 Genomics In Cancer Care Competitive by Company
3.1 Global Genomics In Cancer Care Revenue by Players
3.1.1 Global Genomics In Cancer Care Revenue by Players (2017-2022)
3.1.2 Global Genomics In Cancer Care Market Share by Players (2017-2022)
3.2 Global Genomics In Cancer Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Genomics In Cancer Care Revenue
3.4 Global Genomics In Cancer Care Market Concentration Ratio
3.4.1 Global Genomics In Cancer Care Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomics In Cancer Care Revenue in 2021
3.5 Global Genomics In Cancer Care Key Players Head office and Area Served
3.6 Key Players Genomics In Cancer Care Product Solution and Service
3.7 Date of Enter into Genomics In Cancer Care Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Genomics In Cancer Care Breakdown Data by Type
4.1 Global Genomics In Cancer Care Historic Revenue by Type (2017-2022)
4.2 Global Genomics In Cancer Care Forecasted Revenue by Type (2023-2028)
5 Global Genomics In Cancer Care Breakdown Data by Application
5.1 Global Genomics In Cancer Care Historic Market Size by Application (2017-2022)
5.2 Global Genomics In Cancer Care Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Genomics In Cancer Care Revenue by Company (2020-2022)
6.2 North America Genomics In Cancer Care Revenue by Type (2017-2028)
6.3 North America Genomics In Cancer Care Revenue by Application (2017-2028)
6.4 North America Genomics In Cancer Care Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Genomics In Cancer Care Revenue by Company (2020-2022)
7.2 Europe Genomics In Cancer Care Revenue by Type (2017-2028)
7.3 Europe Genomics In Cancer Care Revenue by Application (2017-2028)
7.4 Europe Genomics In Cancer Care Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Genomics In Cancer Care Revenue by Company (2020-2022)
8.2 Asia Pacific Genomics In Cancer Care Revenue by Type (2017-2028)
8.3 Asia Pacific Genomics In Cancer Care Revenue by Application (2017-2028)
8.4 Asia Pacific Genomics In Cancer Care Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Genomics In Cancer Care Revenue by Company (2020-2022)
9.2 Latin America Genomics In Cancer Care Revenue by Type (2017-2028)
9.3 Latin America Genomics In Cancer Care Revenue by Application (2017-2028)
9.4 Latin America Genomics In Cancer Care Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Genomics In Cancer Care Revenue by Company (2020-2022)
10.2 Middle East and Africa Genomics In Cancer Care Revenue by Type (2017-2028)
10.3 Middle East and Africa Genomics In Cancer Care Revenue by Application (2017-2028)
10.4 Middle East and Africa Genomics In Cancer Care Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Genomics In Cancer Care Products and Services
11.1.4 Illumina Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.1.5 Illumina Genomics In Cancer Care SWOT Analysis
11.1.6 Illumina Recent Developments
11.2 Thermo Fisher scientific
11.2.1 Thermo Fisher scientific Company Details
11.2.2 Thermo Fisher scientific Business Overview
11.2.3 Thermo Fisher scientific Genomics In Cancer Care Products and Services
11.2.4 Thermo Fisher scientific Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.2.5 Thermo Fisher scientific Genomics In Cancer Care SWOT Analysis
11.2.6 Thermo Fisher scientific Recent Developments
11.3 Agilent
11.3.1 Agilent Company Details
11.3.2 Agilent Business Overview
11.3.3 Agilent Genomics In Cancer Care Products and Services
11.3.4 Agilent Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.3.5 Agilent Genomics In Cancer Care SWOT Analysis
11.3.6 Agilent Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Genomics In Cancer Care Products and Services
11.4.4 Roche Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.4.5 Roche Genomics In Cancer Care SWOT Analysis
11.4.6 Roche Recent Developments
11.5 Cancer Genetics
11.5.1 Cancer Genetics Company Details
11.5.2 Cancer Genetics Business Overview
11.5.3 Cancer Genetics Genomics In Cancer Care Products and Services
11.5.4 Cancer Genetics Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.5.5 Cancer Genetics Genomics In Cancer Care SWOT Analysis
11.5.6 Cancer Genetics Recent Developments
11.6 Beckman Coulter
11.6.1 Beckman Coulter Company Details
11.6.2 Beckman Coulter Business Overview
11.6.3 Beckman Coulter Genomics In Cancer Care Products and Services
11.6.4 Beckman Coulter Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.6.5 Beckman Coulter Genomics In Cancer Care SWOT Analysis
11.6.6 Beckman Coulter Recent Developments
11.7 Bio-Rad
11.7.1 Bio-Rad Company Details
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Genomics In Cancer Care Products and Services
11.7.4 Bio-Rad Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.7.5 Bio-Rad Genomics In Cancer Care SWOT Analysis
11.7.6 Bio-Rad Recent Developments
11.8 Danaher
11.8.1 Danaher Company Details
11.8.2 Danaher Business Overview
11.8.3 Danaher Genomics In Cancer Care Products and Services
11.8.4 Danaher Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.8.5 Danaher Genomics In Cancer Care SWOT Analysis
11.8.6 Danaher Recent Developments
11.9 Sigma Aldrich
11.9.1 Sigma Aldrich Company Details
11.9.2 Sigma Aldrich Business Overview
11.9.3 Sigma Aldrich Genomics In Cancer Care Products and Services
11.9.4 Sigma Aldrich Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.9.5 Sigma Aldrich Genomics In Cancer Care SWOT Analysis
11.9.6 Sigma Aldrich Recent Developments
11.10 Pacific Biosciences
11.10.1 Pacific Biosciences Company Details
11.10.2 Pacific Biosciences Business Overview
11.10.3 Pacific Biosciences Genomics In Cancer Care Products and Services
11.10.4 Pacific Biosciences Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.10.5 Pacific Biosciences Genomics In Cancer Care SWOT Analysis
11.10.6 Pacific Biosciences Recent Developments
11.11 Quest Diagnostics
11.11.1 Quest Diagnostics Company Details
11.11.2 Quest Diagnostics Business Overview
11.11.3 Quest Diagnostics Genomics In Cancer Care Products and Services
11.11.4 Quest Diagnostics Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.11.5 Quest Diagnostics Recent Developments
11.12 Luminex
11.12.1 Luminex Company Details
11.12.2 Luminex Business Overview
11.12.3 Luminex Genomics In Cancer Care Products and Services
11.12.4 Luminex Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.12.5 Luminex Recent Developments
11.13 Oxford Gene Technology
11.13.1 Oxford Gene Technology Company Details
11.13.2 Oxford Gene Technology Business Overview
11.13.3 Oxford Gene Technology Genomics In Cancer Care Products and Services
11.13.4 Oxford Gene Technology Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.13.5 Oxford Gene Technology Recent Developments
11.14 PerkinElmer
11.14.1 PerkinElmer Company Details
11.14.2 PerkinElmer Business Overview
11.14.3 PerkinElmer Genomics In Cancer Care Products and Services
11.14.4 PerkinElmer Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.14.5 PerkinElmer Recent Developments
11.15 Qiagen
11.15.1 Qiagen Company Details
11.15.2 Qiagen Business Overview
11.15.3 Qiagen Genomics In Cancer Care Products and Services
11.15.4 Qiagen Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.15.5 Qiagen Recent Developments
11.16 GE Healthcare
11.16.1 GE Healthcare Company Details
11.16.2 GE Healthcare Business Overview
11.16.3 GE Healthcare Genomics In Cancer Care Products and Services
11.16.4 GE Healthcare Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.16.5 GE Healthcare Recent Developments
12 Genomics In Cancer Care Market Dynamics
12.1 Genomics In Cancer Care Market Trends
12.2 Genomics In Cancer Care Market Drivers
12.3 Genomics In Cancer Care Market Challenges
12.4 Genomics In Cancer Care Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Genomics In Cancer Care Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Instruments
Table 3. Key Players of Consumables
Table 4. Key Players of Services
Table 5. Global Genomics In Cancer Care Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Genomics In Cancer Care Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Genomics In Cancer Care Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global Genomics In Cancer Care Revenue Market Share by Region (2017-2022)
Table 9. Global Genomics In Cancer Care Revenue by Players (2017-2022) & (US$ Million)
Table 10. Global Genomics In Cancer Care Market Share by Players (2017-2022)
Table 11. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics In Cancer Care as of 2021)
Table 12. Ranking of Global Top Genomics In Cancer Care Companies by Revenue (US$ Million) in 2021
Table 13. Global 5 Largest Players Market Share by Genomics In Cancer Care Revenue (CR5 and HHI) & (2017-2022)
Table 14. Key Players Headquarters and Area Served
Table 15. Key Players Genomics In Cancer Care Product Solution and Service
Table 16. Date of Key Manufacturers Enter into Genomics In Cancer Care Market
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Genomics In Cancer Care Market Size by Type (2017-2022) & (US$ Million)
Table 19. Global Genomics In Cancer Care Revenue Market Share by Type (2017-2022)
Table 20. Global Genomics In Cancer Care Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 21. Global Genomics In Cancer Care Revenue Market Share by Type (2023-2028)
Table 22. Global Genomics In Cancer Care Market Size by Application (2017-2022) & (US$ Million)
Table 23. Global Genomics In Cancer Care Revenue Market Share by Application (2017-2022)
Table 24. Global Genomics In Cancer Care Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 25. Global Genomics In Cancer Care Revenue Market Share by Application (2023-2028)
Table 26. North America Genomics In Cancer Care Revenue by Company (2020-2022) & (US$ Million)
Table 27. North America Genomics In Cancer Care Revenue by Type (2017-2022) & (US$ Million)
Table 28. North America Genomics In Cancer Care Revenue by Type (2023-2028) & (US$ Million)
Table 29. North America Genomics In Cancer Care Revenue by Application (2017-2022) & (US$ Million)
Table 30. North America Genomics In Cancer Care Revenue by Application (2023-2028) & (US$ Million)
Table 31. North America Genomics In Cancer Care Revenue by Country (2017-2022) & (US$ Million)
Table 32. North America Genomics In Cancer Care Revenue by Country (2023-2028) & (US$ Million)
Table 33. Europe Genomics In Cancer Care Revenue by Company (2020-2022) & (US$ Million)
Table 34. Europe Genomics In Cancer Care Revenue by Type (2017-2022) & (US$ Million)
Table 35. Europe Genomics In Cancer Care Revenue by Type (2023-2028) & (US$ Million)
Table 36. Europe Genomics In Cancer Care Revenue by Application (2017-2022) & (US$ Million)
Table 37. Europe Genomics In Cancer Care Revenue by Application (2023-2028) & (US$ Million)
Table 38. Europe Genomics In Cancer Care Revenue by Country (2017-2022) & (US$ Million)
Table 39. Europe Genomics In Cancer Care Revenue by Country (2023-2028) & (US$ Million)
Table 40. Asia Pacific Genomics In Cancer Care Revenue by Company (2020-2022) & (US$ Million)
Table 41. Asia Pacific Genomics In Cancer Care Revenue by Type (2017-2022) & (US$ Million)
Table 42. Asia Pacific Genomics In Cancer Care Revenue by Type (2023-2028) & (US$ Million)
Table 43. Asia Pacific Genomics In Cancer Care Revenue by Application (2017-2022) & (US$ Million)
Table 44. Asia Pacific Genomics In Cancer Care Revenue by Application (2023-2028) & (US$ Million)
Table 45. Asia Pacific Genomics In Cancer Care Revenue by Region (2017-2022) & (US$ Million)
Table 46. Asia Pacific Genomics In Cancer Care Revenue by Region (2023-2028) & (US$ Million)
Table 47. Latin America Genomics In Cancer Care Revenue by Company (2020-2022) & (US$ Million)
Table 48. Latin America Genomics In Cancer Care Revenue by Type (2017-2022) & (US$ Million)
Table 49. Latin America Genomics In Cancer Care Revenue by Type (2023-2028) & (US$ Million)
Table 50. Latin America Genomics In Cancer Care Revenue by Application (2017-2022) & (US$ Million)
Table 51. Latin America Genomics In Cancer Care Revenue by Application (2023-2028) & (US$ Million)
Table 52. Latin America Genomics In Cancer Care Revenue by Country (2017-2022) & (US$ Million)
Table 53. Latin America Genomics In Cancer Care Revenue by Country (2023-2028) & (US$ Million)
Table 54. Middle East and Africa Genomics In Cancer Care Revenue by Company (2020-2022) & (US$ Million)
Table 55. Middle East and Africa Genomics In Cancer Care Revenue by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Genomics In Cancer Care Revenue by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Genomics In Cancer Care Revenue by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Genomics In Cancer Care Revenue by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Genomics In Cancer Care Revenue by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Genomics In Cancer Care Revenue by Country (2023-2028) & (US$ Million)
Table 61. Illumina Company Details
Table 62. Illumina Business Overview
Table 63. Illumina Genomics In Cancer Care Product and Services
Table 64. Illumina Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 65. Illumina Genomics In Cancer Care SWOT Analysis
Table 66. Illumina Recent Developments
Table 67. Thermo Fisher scientific Company Details
Table 68. Thermo Fisher scientific Business Overview
Table 69. Thermo Fisher scientific Genomics In Cancer Care Product and Services
Table 70. Thermo Fisher scientific Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 71. Thermo Fisher scientific Genomics In Cancer Care SWOT Analysis
Table 72. Thermo Fisher scientific Recent Developments
Table 73. Agilent Company Details
Table 74. Agilent Business Overview
Table 75. Agilent Genomics In Cancer Care Product and Services
Table 76. Agilent Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 77. Agilent Genomics In Cancer Care SWOT Analysis
Table 78. Agilent Recent Developments
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Genomics In Cancer Care Product and Services
Table 82. Roche Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 83. Roche Genomics In Cancer Care SWOT Analysis
Table 84. Roche Recent Developments
Table 85. Cancer Genetics Company Details
Table 86. Cancer Genetics Business Overview
Table 87. Cancer Genetics Genomics In Cancer Care Product and Services
Table 88. Cancer Genetics Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 89. Cancer Genetics Genomics In Cancer Care SWOT Analysis
Table 90. Cancer Genetics Recent Developments
Table 91. Beckman Coulter Company Details
Table 92. Beckman Coulter Business Overview
Table 93. Beckman Coulter Genomics In Cancer Care Product and Services
Table 94. Beckman Coulter Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 95. Beckman Coulter Genomics In Cancer Care SWOT Analysis
Table 96. Beckman Coulter Recent Developments
Table 97. Bio-Rad Company Details
Table 98. Bio-Rad Business Overview
Table 99. Bio-Rad Genomics In Cancer Care Product and Services
Table 100. Bio-Rad Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 101. Bio-Rad Genomics In Cancer Care SWOT Analysis
Table 102. Bio-Rad Recent Developments
Table 103. Danaher Company Details
Table 104. Danaher Business Overview
Table 105. Danaher Genomics In Cancer Care Product and Services
Table 106. Danaher Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 107. Danaher Genomics In Cancer Care SWOT Analysis
Table 108. Danaher Recent Developments
Table 109. Sigma Aldrich Company Details
Table 110. Sigma Aldrich Business Overview
Table 111. Sigma Aldrich Genomics In Cancer Care Product and Services
Table 112. Sigma Aldrich Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 113. Sigma Aldrich Genomics In Cancer Care SWOT Analysis
Table 114. Sigma Aldrich Recent Developments
Table 115. Pacific Biosciences Company Details
Table 116. Pacific Biosciences Business Overview
Table 117. Pacific Biosciences Genomics In Cancer Care Product and Services
Table 118. Pacific Biosciences Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 119. Pacific Biosciences Genomics In Cancer Care SWOT Analysis
Table 120. Pacific Biosciences Recent Developments
Table 121. Quest Diagnostics Company Details
Table 122. Quest Diagnostics Business Overview
Table 123. Quest Diagnostics Genomics In Cancer Care Product and Services
Table 124. Quest Diagnostics Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 125. Quest Diagnostics Recent Developments
Table 126. Luminex Company Details
Table 127. Luminex Business Overview
Table 128. Luminex Genomics In Cancer Care Product and Services
Table 129. Luminex Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 130. Luminex Recent Developments
Table 131. Oxford Gene Technology Company Details
Table 132. Oxford Gene Technology Business Overview
Table 133. Oxford Gene Technology Genomics In Cancer Care Product and Services
Table 134. Oxford Gene Technology Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 135. Oxford Gene Technology Recent Developments
Table 136. PerkinElmer Company Details
Table 137. PerkinElmer Business Overview
Table 138. PerkinElmer Genomics In Cancer Care Product and Services
Table 139. PerkinElmer Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 140. PerkinElmer Recent Developments
Table 141. Qiagen Company Details
Table 142. Qiagen Business Overview
Table 143. Qiagen Genomics In Cancer Care Product and Services
Table 144. Qiagen Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 145. Qiagen Recent Developments
Table 146. GE Healthcare Company Details
Table 147. GE Healthcare Business Overview
Table 148. GE Healthcare Genomics In Cancer Care Product and Services
Table 149. GE Healthcare Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 150. GE Healthcare Recent Developments
Table 151. Genomics In Cancer Care Market Trends
Table 152. Genomics In Cancer Care Market Drivers
Table 153. Genomics In Cancer Care Market Challenges
Table 154. Genomics In Cancer Care Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genomics In Cancer Care Sales Market Share by Type: 2021 VS 2028
Figure 2. Instruments Features
Figure 3. Consumables Features
Figure 4. Services Features
Figure 5. Global Genomics In Cancer Care Sales Market Share by Application: 2021 VS 2028
Figure 6. Diagnostics Case Studies
Figure 7. Personalized Medicine Case Studies
Figure 8. Drug Discovery Case Studies
Figure 9. Development Case Studies
Figure 10. Research Case Studies
Figure 11. Genomics In Cancer Care Report Years Considered
Figure 12. Global Genomics In Cancer Care Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Genomics In Cancer Care Market Size 2017-2028 (US$ Million)
Figure 14. Global Genomics In Cancer Care Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Genomics In Cancer Care Revenue Market Share by Region in 2017 VS 2022
Figure 16. Global Top 10 Genomics In Cancer Care Countries Ranking by Market Size (US$ Million) in 2021
Figure 17. Global Genomics In Cancer Care Market Share by Players in 2021
Figure 18. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics In Cancer Care as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Genomics In Cancer Care Revenue in 2021
Figure 20. North America Genomics In Cancer Care Revenue Market Share by Company in 2021
Figure 21. North America Genomics In Cancer Care Revenue Market Share by Type (2017-2028)
Figure 22. North America Genomics In Cancer Care Revenue Market Share by Application (2017-2028)
Figure 23. North America Genomics In Cancer Care Revenue Share by Country (2017-2028)
Figure 24. U.S. Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 25. Canada Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 26. Europe Genomics In Cancer Care Revenue Market Share by Company in 2021
Figure 27. Europe Genomics In Cancer Care Revenue Market Share by Type (2017-2028)
Figure 28. Europe Genomics In Cancer Care Revenue Market Share by Application (2017-2028)
Figure 29. Europe Genomics In Cancer Care Revenue Share by Country (2017-2028)
Figure 30. Germany Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 31. France Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 32. U.K. Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 33. Italy Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 34. Russia Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Genomics In Cancer Care Revenue Market Share by Company in 2021
Figure 36. Asia Pacific Genomics In Cancer Care Revenue Market Share by Type (2017-2028)
Figure 37. Asia Pacific Genomics In Cancer Care Revenue Market Share by Application (2017-2028)
Figure 38. Asia Pacific Genomics In Cancer Care Revenue Share by Region (2017-2028)
Figure 39. China Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 40. Japan Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 41. South Korea Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 42. India Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 43. Australia Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 44. Taiwan Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 45. Indonesia Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 46. Thailand Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 47. Malaysia Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 48. Philippines Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 49. Vietnam Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 50. Latin America Genomics In Cancer Care Revenue Market Share by Company in 2021
Figure 51. Latin America Genomics In Cancer Care Revenue Market Share by Type (2017-2028)
Figure 52. Latin America Genomics In Cancer Care Revenue Market Share by Application (2017-2028)
Figure 53. Latin America Genomics In Cancer Care Revenue Share by Country (2017-2028)
Figure 54. Mexico Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 55. Brazil Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 56. Argentina Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 57. Middle East and Africa Genomics In Cancer Care Revenue Market Share by Company in 2021
Figure 58. Middle East and Africa Genomics In Cancer Care Revenue Market Share by Type (2017-2028)
Figure 59. Middle East and Africa Genomics In Cancer Care Revenue Market Share by Application (2017-2028)
Figure 60. Middle East and Africa Genomics In Cancer Care Revenue Share by Country (2017-2028)
Figure 61. Turkey Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 62. Saudi Arabia Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 63. UAE Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
Figure 64. Illumina Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 65. Thermo Fisher scientific Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 66. Agilent Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 67. Roche Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 68. Cancer Genetics Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 69. Beckman Coulter Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 70. Bio-Rad Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 71. Danaher Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 72. Sigma Aldrich Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 73. Pacific Biosciences Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 74. Quest Diagnostics Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 75. Luminex Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 76. Oxford Gene Technology Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 77. PerkinElmer Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 78. Qiagen Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 79. GE Healthcare Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
  • Global Agrigenomics Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 87
    Agrigenomics is product and scientific services in genomics field for agriculture and livestock. Include DNA extraction and purification, DNA/RNA sequencing, Genotyping, Gene expression profiling, Marker-assisted selection, GMO/Trait purity and other technology. The global Agrigenomics market was valued at US$ 4849.2 million in 2023 and is anticipated to reach US$ 7524.5 million by 2030, witnessing a CAGR of 6.4% during The forecast period 2024-2030. Thermo Fisher Scientific,......
  • Global Agrigenomics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108
    According to our LPI (LP Information) latest study, the global Agrigenomics market size was valued at US$ 4743.7 million in 2023. With growing demand in downstream market, the Agrigenomics is forecast to a readjusted size of US$ 7439.4 million by 2030 with a CAGR of 6.6% during review period. The research report highlights the growth potential of the global Agrigenomics market. Agrigenomics are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Agrigenomics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108
    According to our (Global Info Research) latest study, the global Agrigenomics market size was valued at USD 4989.6 million in 2023 and is forecast to a readjusted size of USD 7564.5 million by 2030 with a CAGR of 6.1% during review period. Agrigenomics is product and scientific services in genomics field for agriculture and livestock. Include DNA extraction and purification, DNA/RNA sequencing, Genotyping, Gene expression profiling, Marker-assisted selection, GMO/Trait purity and other t......
  • Global Gene Editing Market Research Report 2023
    Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 97
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gene Editing market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Thermo Fisher Scientific - Merck - Horizo??n Discovery - Sangamo BioSciences - Integrated DNA Technologies - Lonza - New England Biolabs - ......
  • Global Agrigenomics Professional Survey Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 101
    Agricultural genomics (AgriGenomics) is the application of genomics in agriculture to improve the productivity and sustainability in crop and livestock production. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Te......
  • Global Agrigenomics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Nov-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Agrigenomics market: According to our latest research, the global Agrigenomics market looks promising in the next 5 years. As of 2022, the global Agrigenomics market was estimated at USD 5139.47 million, and it's anticipated to reach USD 7676.54 million in 2028, with a CAGR of 6.92% during the forecast years. Agrigenomics is defined as the study of the genetic makeup of crops and livestock and how genes influence the produce. Application of genomics ......
  • Global Agrigenomics Market Research Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166
    Agricultural genomics (AgriGenomics) is the application of genomics in agriculture to improve the productivity and sustainability in crop and livestock production. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Te......
  • Global Genomics in Cancer Care Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Nov-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Genomics in Cancer Care market: According to our latest research, the global Genomics in Cancer Care market looks promising in the next 5 years. As of 2022, the global Genomics in Cancer Care market was estimated at USD 4369.0 million, and it's anticipated to reach USD 11429.15 million in 2028, with a CAGR of 17.38% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of ......
  • Gene Editing Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 200
    Gene Editing Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gene editing deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of gene editing deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter gene editing deals. These deals tend to be multicomponent, starting with collaborative R&D, and ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs